UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) JUNE 28, 2002 ASTRO-MED, INC (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) COMMISSION FILE NUMBER 0-13200 RHODE ISLAND 05-0318215 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION INCORPORATION OR ORGANIZATION) NUMBER) 600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE) (401-828-4000) (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT. On June 28, 2002, acting upon the recommendation of its Audit Committee, the Board of Directors of Astro-Med, Inc. (the Company) dismissed the Company's independent auditors, Arthur Andersen LLP (AA). The Company is in the process of interviewing qualified independent auditors to replace AA and anticipates that it will have reached agreement with a nationally recognized public accounting firm shortly. During the two most recent fiscal years of the Company ended January 31, 2002 and 2001, and the subsequent interim period through June 28, 2002, there were no disagreements between the Company and AA on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to AA's satisfaction, would have caused AA to make reference to the subject matter of the disagreement in connection with its reports; and there were no reportable events described under Item 304 (a) (1) (v) of Regulation S-K. The audit reports of AA on the consolidated financial statements of the Company as of and for the fiscal years ended January 31, 2002 and 2001 did not contain any adverse opinion or disclaimers of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. A letter from AA attached hereto as Exhibit 16.1, indicating its concurrence with disclosures in this and the preceding paragraph. During the two most recent fiscal years of the Company ended January 31, 2002 and 2001 and the subsequent interim period through June 28, 2002, the Company did not consult any other firms regarding any of the matters or events set forth in Item 304 (a) (2) (i) and (ii) of Regulation S-K. ITEM 7. FINANCIAL STATEMENTS, PROFORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits. Exhibit 16.1 - Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated June 28, 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized. DATE: JUNE 28, 2002 ASTRO-MED, INC. By: /s/ Joseph P. O'Connell Vice President and Treasurer Chief Financial Officer EXHIBIT INDEX EXHIBIT DESCRIPTION 16.1 Letter from Arthur Andersen LLP to the Securities and Exchange Commission Dated June 28, 2002. EXHIBIT 16.1 June 28, 2002 Office of the Chief Accountant Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Dear Sir or Madam: The representations made in this letter are based solely on discussions with and representations from the engagement partner and manager on the audits of the financial statements of this registrant for the two most recent fiscal years. Those individuals are no longer with Arthur Andersen LLP. We have read the first three paragraphs of Item 4 included in the Form 8-K dated June 28, 2002, of Astro-Med, Inc. to be filed with the Securities and Exchange Commission and have found no basis for disagreement with the statements contained therein. Very truly yours, /s/ Arthur Andersen LLP cc: Mr. Joseph P. O'Connell, CFO, Astro-Med, Inc.
AstroNova (ALOT) 8-KChanges in registrant's certifying accountant
Filed: 28 Jun 02, 12:00am